Recruiting

Robotic Telesurgery in Remote Healthcare Settings

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Telesurgery utilizing Microport Medbot Robotic Platform

Device
Who is being recruted

Urogenital Diseases
+2

+ Genital Diseases
+ Genital Diseases, Male
From 18 to 90 Years
See all eligibility criteria
How is the trial designed

Device Feasibility Study

Interventional
Study Start: June 2025
See protocol details

Summary

Principal SponsorAdventHealth
Last updated: December 11, 2025
Sourced from a government-validated database.Claim as a partner
Study start date: June 14, 2025Actual date on which the first participant was enrolled.

This study is exploring the use of robotic telesurgery, which is a type of surgery performed by a specialized surgeon from a distance using a secure internet connection. The main goal is to determine how safe and effective this method is when applied in real hospital settings. By assessing its functionality in different environments and identifying potential technical issues, like internet speed or delays, the study aims to improve surgical care in remote areas. Additionally, this research is important as it could lead to the development of new training methods for upcoming surgeons. Participants in this study will be involved in surgeries where a surgeon operates remotely using robotic technology. The study will monitor how well the surgery is performed and any issues that arise during the procedure. It will evaluate the technical aspects of telesurgery, focusing on factors like internet connectivity and any delays that might affect the surgery. By analyzing these aspects, the study hopes to enhance the effectiveness and reliability of telesurgery, ultimately benefiting both patients and medical professionals.

Official TitleAdvancing Humanitarian Healthcare: Exploring the Potential of Robotic Telesurgery in Remote Settings - A Multicentric Prospective Study 
NCT07130708
Principal SponsorAdventHealth
Last updated: December 11, 2025
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details
10 patients to be enrolledTotal number of participants that the clinical trial aims to recruit.
Device Feasibility Study
These studies test whether a new medical device (like a tool or piece of equipment) is safe and practical to use. They're usually small and focus on how the device works rather than how well it treats a condition.

How participants are assigned to different groups/arms
In this clinical study, all participants receive the same treatment. Since there is only one group, there is no need for randomization or assignment to different arms. This type of study is often used to test a new treatment without comparing it to another.

Other Ways to Assign Participants
Randomized allocation: Participants are assigned randomly, like flipping a coin, to ensure fairness and reduce bias.
Non-randomized allocation: Participants are assigned based on specific factors, such as their medical condition or a doctor's decision.

How treatments are given to participants
In this study, all participants receive the same treatment. This approach is often used to evaluate the effects of a single intervention without comparing it to another.

Other Ways to Assign Treatments
Parallel assignment: Participants are split into separate groups, each receiving a different treatment.
Cross-over assignment: Participants switch between treatments during the study.
Factorial assignment: Participants receive different combinations of treatments.
Sequential assignment: Participants receive treatments one after another in a specific order, possibly based on individual responses.
Other assignment: Treatment assignment does not follow a standard or predefined design.

How the effectiveness of the treatment is controlled
In a non placebo-controlled study, no participants receive an inert substance (placebo) to compare outcomes. Instead, all participants receive either the experimental treatment or an alternative treatment (often the Standard of Care). This method allows researchers to compare the effects of the experimental treatment with those of a different active intervention, rather than a placebo.

Other Options
Placebo-Controlled: A placebo is used to compare the effects of the experimental treatment with those of an inert substance, isolating the true treatment effect.

How the interventions assigned to participants is kept confidential
Everyone involved in the study knows which treatment is being given. This is typically used when it's not possible or necessary to hide the treatment details from participants or researchers.

Other Ways to Mask Information
Single-blind: Participants do not know which treatment they are receiving, but researchers do.
Double-blind: Neither participants nor researchers know which treatment is given.
Triple-blind: Participants, researchers, and outcome assessors do not know which treatment is given.
Quadruple-blind: Participants, researchers, outcome assessors, and care providers all do not know which treatment is given.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria
MaleBiological sex of participants that are eligible to enroll.
From 18 to 90 YearsRange of ages for which participants are eligible to join.
Healthy volunteers not allowedIf individuals who are healthy and do not have the condition being studied can participate.
Conditions
Pathology
Urogenital Diseases
Genital Diseases
Genital Diseases, Male
Prostatic Diseases
Male Urogenital Diseases
Criteria

Inclusion Criteria: * Age 18 - 90 * Male or female * Eligible participants for this telesurgery study must have a clearly defined indication for robotic urologic surgery, specifically: * Localized Prostate Cancer (ICD-10: C61), appropriate for robotic radical prostatectomy. OR -Benign Prostate diseases appropriate for robotic simple prostatectomy (ICD-10: N40) These diagnoses are confirmed by clinical examination, imaging, and/or pathology prior to surgical planning. Patients with vague or unspecified urologic conditions will be excluded to ensure the safety and appropriateness of the surgical intervention. * Primary diagnosis of urinary system disease and prostate disorders (C61 and N40.1) scheduled to undergo treatment with robotic surgery. These patients don't have access to robotic surgery in their routine and the study will give them the opportunity to have advanced technology and the gold-standard treatment with experts in the field. * Willing to participate in the study * Mentally capable of comprehending the study protocol Exclusion Criteria: * Patients who, based on multidisciplinary evaluation (surgical, anesthetic, and medical), are deemed not suitable for robotic surgery due to high perioperative risk. This includes but is not limited to: * Uncontrolled cardiovascular, pulmonary, or metabolic disease. * Severe anesthetic risk classified as ASA Class IV or higher. * Patients enrolled in another interventional research study that may interfere with surgical safety or outcomes. * Patients unwilling or unable to comply with the perioperative and follow-up schedule. * Vulnerable populations are excluded from this study, including: * Minors (under 18 years old) * Prisoners * Cognitively impaired or decisional incapacitated individuals

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives
One single intervention group 

is designated in this study

This study does not include a placebo group 

Treatment Groups
Group I
Experimental
Telesurgery

A robotic surgery for prostate disease via telesurgery, where a highly trained surgeon performs the operation remotely using a secure internet connection.
Study Objectives
Primary Objectives

One of the investigator's primary outcome measures is the safety and feasibility of the Microport Medbot Robotic Platform for use in Telesurgery through maintaining a stable connection. The investigator will monitor feasibility through perioperative connectivity assessment provided by the platform. Outcome of Latency- Medbot platform measures in milliseconds. This is monitored by the investigator. Measured in Milliseconds per round trip time (ms/RTT). The acceptable threshold is under 200ms. Robotic Platform Performance Logs- The robotic system itself continuously logs and reports performance metrics, including latency. Dedicated Tech team: Oversees and monitors connection status throughout procedure.

Investigators assessment of and response to perioperative complications (complications observed will be classified using the Clavien-Dindo Classification with Grades I thru V).

One of the investigator's primary outcome measures is the safety and feasibility of the Microport Medbot Robotic Platform for use in Telesurgery through maintaining a stable connection. The investigator will monitor feasibility through perioperative connectivity Outcome: Bandwidth and Network Stability- The surgical team monitors bandwidth to ensure a consistent, high-speed internet connection. Bandwidth measured in megabits per second (Mbps). The goal of 100Mbps is recommended. Measurement is made through tracking on data transmission rates reported by the robotic system itself which continuously logs and reports data in real time. Dedicated Tech Team: Oversees and monitors connection status throughout the procedure.

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.
This study has 1 location
Recruiting
AdventHealthCelebration, United StatesSee the location
Recruiting
One Study Center
;